The University of Toronto’s Leslie Dan Faculty of Pharmacy has developed two new edX online courses to help patients and healthcare providers better understand switching to biosimilars.
Under the proposal, as many as 10 drug makers would be required every year to furnish the government with proprietary and non-proprietary information as evidence to support the price it charges states.